Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13 EUR | +8.33% | -.--% | -.--% |
05-23 | EVOTEC : Deutsche Bank maintains a Buy rating | ZD |
05-22 | Evotec Shares Rise Following Gene Therapy Exit, Q1 Results | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.7B | - | |||||
63.85B | - | |||||
41.83B | ||||||
40.65B | ||||||
27.12B | ||||||
26.52B |
- Stock Market
- Equities
- EVT Stock
- EVT Stock
- Charts Evotec
- Sector Chart